Eltrombopag waa magaca guud ee magaca ganacsiga daroogada Promacta. Xaaladaha qaarkood, xirfadlayaasha daryeelka caafimaadku waxay isticmaali karaan magaca ganacsiga, Promacta, marka ay tixraacayaan magaca daawada guud, eltrombopag.

Daawadan waxaa loo isticmaalaa in lagu daweeyo heerarka hoose ee platelet ee dadka qaba cillad dhiig oo gaar ah oo loo yaqaan chronic immune (idiopathic) trombocytopenia purpura (ITP) ama kuwa qaba cagaarshow C dabadheeraad ah. Waxa kale oo loo isticmaali karaa in lagu daweeyo dadka qaba cillad dhiig oo gaar ah dhiig-yaraan).

Eltrombopag waxaa loo isticmaalaa si looga hortago dhacdooyinka dhiigbaxa ee dadka waaweyn iyo carruurta da'doodu tahay 1 sano iyo ka weyn, kuwaas oo leh dabadheeraad ahthrombocytopenic purpura ee difaaca jirka(ITP). ITP waa xaalad dhiigbax ah oo ay keento la'aanta platelet ee dhiigga.

Eltrombopag dawo uma aha ITP kamana dhigi doonto platelet-kaaga tirinta caadiga ah haddii aad qabto xaaladdan.

Eltrombopag waxa kale oo loo isticmaalaa si looga hortago dhiigbaxa dadka waaweyn ee qaba cagaarshow C daba-dheer kuwaas oo lagu daaweeyo interferon (sida Intron A, Infergen, Pegasys, PegIntron, Rebetron, Redipen, ama Sylatron).

Eltrombopag waxa kale oo lala isticmaalaa dawooyin kale si loo daweeyo darandhiig-yaraanta aplasticdadka waaweyn iyo carruurta ka yar 2 sano.

Eltrombopag ayaa mararka qaarkood la bixiyaa ka dib marka daawaynta kale ay guul darreysato.

Eltrombopag looma isticmaalo daaweynta myelodysplastic syndrome (sidoo kale loo yaqaan "preleukemia").

Eltrombopag waxa kale oo loo isticmaali karaa ujeedooyin aan lagu xusin hagaha daawaynta.